Demodicosis
can present as localized or generalized disease and can be squamous
or pustular. Localized disease occurs commonly on the face, head,
and distal forelimbs. Five or fewer lesions can be classified
as localized disease. Localized lesions may wax and wane over
several months. Approximately 10% of localized disease will progress
to the generalized form of the disease. Dogs with six lesions,
pododemodicosis or one major body region affected can be classified
with generalized disease. Most dogs with demodicosis are non-pruritic.
Squamous demodicosis can present as diffuse erythematous scaling
dermatitis with follicular plugging and follicular casts along
the hair shafts. Large areas of prominent hyperpigmentation with
comedones and erythema with or without alopecia
|
Pustular
demodicosis of the face and head
|
|
may also be seen.
Pustular demodicosis occurs as a result of secondary pyoderma and/or
furunculosis associated with the demodicosis.
Dogs with pododemodicosis may exhibit interdigital nodules, draining tracts
and severe digital edema and swelling. Footpad hyperkeratosis may be seen in
dogs with pododemodicosis. Dogs with generalized
deep pustular demodicosis may be depressed,
lethargic |
and febrile.
Generalized lymphadenopathy can also occur. In a small number of
cases, pruritic ceruminous otitis associated with demodex may be
the sole clinical finding or may be present concurrently with localized
or generalized disease. The diagnosis is made by identifying mites
from deep skin scrape samples, and some dogs may require sedationto
obtain adequate samples. In rare cases a skin biopsy may be required
to make the diagnosis. |
is the large animal preparation
Taktic EC®. Taktic® is
12.5 % amitraz. To achieve the 250 ppm concentration, use 16.8 ml in 2 gallons
of water. Dogs should
be clipped short and bathed with a benzoyl peroxide shampoo prior
to dipping. Dips should be applied every 7-14 days. Additional
non-approved treatments include ivermectin and milbemycin.
|
One percent ivermectin
is used at a dose of
400-600 mcg/kg orally once daily. The target
dose should be gradually reached by starting with
a dose of 100
mcg/kg and increasing by 100 mcg/kg until the target dose is reached.
Alternatively, milbemycin oxime (Interceptor®) is dosed orally
at 2 mg/kg once |
daily. Treatment
duration is 2-4 months. Side effects are uncommon and typically
reversible and may include ataxia, trembling and stupor. Milbemycin
oxime should be used with caution in collies and puppies younger
than 12 weeks of age. Milbemycin and ivermectin both appear effective
in 80-85% of dogs with generalized demodicosis. |